References
- Nagano M., Higaki J., Mikami H., Nakamaru M., Higashimori K., Katahira K., Tabuchi Y., Moriguchi A., Nakamura F., Ogihara T. Converting enzyme inhibitors regressed cardiac hypertrophy and reduced tissue angiotensin II in spontaneously hypertensive rats. J Hypertens. 1991; 9: 595–599
- Schunkert H., Dzau V. J., Tang S. S., Hirsch A. T., Apstein C. S., Lorell B. H. Increased rat cardiac angiotensin converting enzyme activity and mRNA expression in pressure overload left ventricular hypertrophy. J Clin Invest. 1990; 86: 1913–1920
- Sadoshima J. I., Izumo S. Molecular characterization of angiotensin II-induced hypertrophy of cardiac myocytes and hyperplasia of acrdiac fibroblasts. Circ Res. 1993; 73: 413–423
- Nakamura F., Nagano M., Higaki J., Higashimori K., Morishita R., Mikami H., Ogihara T. The angiotensin-converting enzyme inhibitor prevents cardiac hypertrophy in low-renin hypertensive rats. Clin Exp Pharmacol Physiol. 1993; 20: 135–140
- Baumgarten C. R., Linz W., Kunkel G., Schölkens B. A., Wiemer G. Ramiprilat increases bradykinin outflow from isolated hearts of rat. Br J Pharmacol. 1993; 108: 293–295
- Linz W., Schölkens B. A. A specific B2-bradykinin receptor antagonist HOE140 abolishes the antihypertrophic effect of ramipril. Br J Pharmacol. 1992; 105: 771–772
- Gavras H., Brunner H. R., Thurston H., Laragh J. H. Reciprocation of renin dependency in renal hypertension. Science 1979; 188: 1316–1320
- Griffin S. A., Brown C. B., MacPherson F., McGrath J. C., Wilson V. G., Korsgaard N., Mulvany M. J., Lever A. F. Angiotensin II causes vascular hypertrophy in part by a non-pressor mechanism. Hypertension 1991; 17: 626–635
- Wirth K., Hock F. J., Albus U., Linz W., Alpermann H. G., Anagnostopoulos H., Henke S., Breipohl G., König W., Knolle J., Schölkens B. A. Hoe140 a new potent and long-acting bradykinin-antagonist: in vivo studies. Br J Pharmacol. 1991; 102: 774–777
- Jover B., Saladini D., Nafrialdi N., Dupont M., Mimran A. Effect of losartan and enalapril on renal adaptation to sodium restriction in rat. Am J Physiol 1994; 267: F281–F288, (Renal Fluid Electrolyte Physiol 36)
- Unger T., Mattfeldt T., Lamberty V., Bock P., Mall G., Linz W., Schölkens B. A., Gohlke P. Effect of early onset angiotensin converting enzyme inhibition on myocardial capillaries. Hypertension 1992; 20: 478–482
- Gohlke P., Linz W., Schölkens B. A., Kuwer I., Bartenbach S., Schnell A., Unger T. Angiotensin-converting enzyme inhibition improves cardiac function. Role of bradykinin. Hypertension 1994; 23: 411–418
- Danser J. A.H., van Kats J. P., Admiraal P. J.J., Derkx F. H.M., Lamers J. M.J., Verdouw P. D., Saxena P. R., Schalekamp M. A.D.H. Cardiac renin and angiotensins. Uptake from plasma versus in situ synthesis. Hypertension 1994; 24: 37–48
- O'Sullivan J. B., Black M. J., Bertram J. F., Bobik A. Cardiovascular hypertrophy in one-kidney one clip renal hypertensive rats: a role for angiotensin II?. J Hypertens. 1994; 12: 1163–1170
- Seyedi N., Xu X. B., Nasjletti A., Hintze T. H. Coronary kinin generation mediates nitric oxide release after angiotensin receptor stimulation. Hypertension 1995; 26: 164–170
- Hou J., Kato H., Cohen R. A., Chobanian A. V., Brecher P. Angiotensin II-induced cardiac fibrosis in the rat is increased by chronic inhibition of nitric oxide synthase. J Clin Invest. 1995; 96: 2469–2477